Skip to main content

Table 3 Characteristics of the interviewees by study group

From: Using life course charts to assess and compare trajectories of amphetamine type stimulant consumption in different user groups: a cross-sectional study

 

Group 1: currently ATS dependent (CDU)

Group 2: formerly ATS dependent users (FDU)

Group 3: currently frequent, non-dependent ATS users (CFU)

Group 4: formerly frequent, non-ATS dependent users (FFU)

Group 5: non-frequent ATS users (currently and formerly) (NFU)

Group 6: exposed non-ATS users (ENU)

Total

N

47

56

48

37

49

42

279

Female

46.8%

44.6%

25.0%

45.9%

40.8%

45.2%

41.2%

Mean age (SD)

32.2 (7.7)

33.6 (8.6)

29.3 (6.8)

32.6 (9.5)

31.0 (7.6)

28.8 (6.8)

31.3 (8.0)

Mean age of onset/exposure ATS use (SD)

16.6 (2.2)

17.6 (4.7)

18.6 (4.0)

17.0 (4.3)

18.8 (3.8)

17.6 (3.4)

17.7 (3.9)

Mean duration of ATS use/exposition in years (SD)

15.5 (8.0)

12.5 (6.8)

10.7 (5.3)

9.9 (6.8)

8.5 (6.5)

11.2 (6.1)

11.5 (6.9)

Ever contact with drug service

68.1%

78.6%

25.0%

29.7%

22.4%

0.0%

39.4%

SDS ATS score (SD)

7.2 (2.8)

7.3 (3.4)

1.9 (1.6)

2.2 (1.8)

0.3 (1.2)

0.0 (0.0)

3.3 (3.8)

Daily ATS use (almost)

74.5%

70.9%

20.8%

22.2%

4.1%

0.0%

33.9%

Daily/weekly amphetamine use

80.9%

71.4%

45.8%

29.7%

22.4%

0.0%

43.7%

Daily/weekly methamphetamine use

21.3%

30.4%

6.3%

10.8%

0.0%

0.0%

12.2%

Daily/weekly MDMA use

44.7%

50.0%

37.5%

35.1%

10.2%

0.0%

30.5%

Ever used cannabis

91.5%

96.4%

91.7%

94.6%

91.8%

78.6%

91.0%

Ever used cocaine

66.0%

62.5%

60.4%

83.8%

51.0%

4.8%

54.8%

Ever daily alcohol use

48.9%

51.8%

27.1%

40.5%

42.9%

28.6%

40.5%